Skip to content

CorMedix CRMD Other Working Capital

Other Working Capital at other companies

Merit Medical Systems logo
Merit Medical SystemsMMSI
-$314K-103%
ITG
Integer HoldingsITGR
-$716K+72.2%
Emergent Biosolutions logo
Emergent BiosolutionsEBS
$3.9M-65.5%
Abbott logo
AbbottABT
$420M-3.7%
ICU Medical logo
ICU MedicalICUI
-$2.99M+67.6%
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
$278K-21.9%

Other financials

Income statement

See full
Revenue$127.4M+226%
Gross profit$115.4M+207%
Operating income$63.7M+216%
Net income$38.6M+87.0%
EPS (diluted)$0.43+43.3%

Balance sheet

See full
Cash & equivalents$179.1M+170%
Total debt$4.3M+729%
Total equity$437.0M+280%
Total assets$815.6M+445%

Cash flow

See full
Operating cash flow$42.4M+115%
CapEx$729.0K+7,190%
Free cash flow$41.7M+111%

Valuation

See full
Market cap$605.65M-34.4%
P/E3.4×
P/S1.5×-9.6×

Profitability

See full
Gross margin91.9%-3.5pp
Operating margin48.4%
Net margin45.2%
FCF margin48.7%+38.8pp

Returns & leverage

See full
Return on equity65.6%
Debt / equity0.0×
Current ratio-1.2×

Where this comes from

Reported directly by CorMedix in its filing.

Tagged under the XBRL concept us-gaap:OtherNoncashIncomeExpense.

The official record: CorMedix’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about CorMedix's other working capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CorMedix's other working capital?
CorMedix (CRMD) reported other working capital of -$672K in Q1 2026.
How has CorMedix's other working capital changed year-over-year?
CorMedix's other working capital decreased by 1360.9% year-over-year, from -$46K to -$672K.
What does other working capital mean?
Net change in working capital items not separately classified — a residual balancing item.